RE: US shutdown and CRLs15 Feb 2019 09:20
FDA Situation: Experts say this could have a ripple effect, bogging down the approval and manufacture of new drugs, delaying patients from getting these treatments and adding to a host of other crucial FDA actions and oversight that have taken a hit during the shutdown.